Ketamine Hydrochloride

Verify with FDA CVM →

1,757 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,757
Total Reports
422
Deaths Reported
2400.0%
Death Rate

Active Ingredients

Ketamine Hydrochloride

Administration Routes

UnknownIntramuscularIntravenousIntraperitonealSubcutaneousOtherParenteralOphthalmicIntrapleuralOral

Species Affected

Cat 673
Dog 499
Horse 276
Unknown 134
Rat 34
Mouse 33
Rabbit 22
Monkey 16
Other 16
Pig 9

Most Affected Breeds

Unknown 254
Domestic Shorthair 200
Domestic (unspecified) 190
Cat (unknown) 159
Dog (unknown) 131
Horse (unknown) 97
Quarter Horse 61
Retriever - Labrador 45
Crossbred Canine/dog 42
Domestic Longhair 30

Most Reported Reactions

INEFFECTIVE, ANESTHESIA 340
Death 330
Lack of efficacy - NOS 188
INEFFECTIVE, SEDATION 185
Cardiac arrest 129
Apnoea 96
Recovery prolonged 84
Seizure NOS 81
Fever 68
Convulsion 57
Hyperthermia 53
Death by euthanasia 52

Outcome Breakdown

Recovered/Normal
621 (50.1%)
Died
367 (29.6%)
Outcome Unknown
128 (10.3%)
Ongoing
66 (5.3%)
Euthanized
55 (4.4%)
Recovered with Sequela
2 (0.2%)

Data Summary

Metric Value
Total adverse event reports 1,757
Reports involving death 422
Case-fatality rate (reported events) 2400.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ketamine Hydrochloride Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,757 adverse event reports referencing Ketamine Hydrochloride, including 422 reports in which the animal died — a 2400.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ketamine Hydrochloride. Reported administration routes include Unknown, Intramuscular, Intravenous, Intraperitoneal. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ketamine Hydrochloride reports are Cat (673 reports), Dog (499 reports), Horse (276 reports), with Cat accounting for the largest share. Within those species, Unknown (254), Domestic Shorthair (200), Domestic (unspecified) (190) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ketamine Hydrochloride are INEFFECTIVE, ANESTHESIA (340), Death (330), Lack of efficacy - NOS (188), INEFFECTIVE, SEDATION (185). Of the 1,239 reports with a coded outcome, Recovered/Normal is the leading category at 50.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ketamine Hydrochloride.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial